Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANAB Anaptysbio Inc

盘前交易 07-23 09:21:49 EDT

35.71

+2.01

+5.96%

盘前36.24

+0.53+1.48%

08:23 EDT

最高35.75	最低33.87	成交量32.71万
今开34.34	昨收33.70	日振幅5.58%
总市值9.76亿	流通市值6.22亿	总股本2,732万
成交额1,146万	换手率1.88%	流通股本1,743万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANAB","market":"US","secType":"STK","nameCN":"Anaptysbio Inc","latestPrice":35.71,"timestamp":1721678400000,"preClose":33.7,"halted":0,"volume":327067,"hourTrading":{"tag":"盘前","latestPrice":36.24,"preClose":35.71,"latestTime":"08:23 EDT","volume":1,"amount":36.24,"timestamp":1721737387808},"delay":0,"floatShares":17428699,"shares":27318644,"eps":-6.134813,"marketStatus":"盘前交易","marketStatusCode":1,"change":2.01,"latestTime":"07-23 09:21:49 EDT","open":34.34,"high":35.75,"low":33.87,"amount":11455451.028528,"amplitude":0.055786,"askPrice":41.84,"askSize":600,"bidPrice":22.4,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-6.134813,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721741400000},"adr":0,"listingDate":1485406800000,"adjPreClose":35.71,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":36.24,"preClose":35.71,"latestTime":"08:23 EDT","volume":1,"amount":36.24,"timestamp":1721737387808},"postHourTrading":{"tag":"盘后","latestPrice":35.71,"preClose":35.71,"latestTime":"19:49 EDT","volume":6905,"amount":246621.4,"timestamp":1721692186385},"volumeRatio":0.7200851597398705,"impliedVol":0.7778,"impliedVolPercentile":0.745},"requestUrl":"/m/hq/s/ANAB","defaultTab":"news","newsList":[{"id":"2453792825","title":"美国研究综述-Align Technology、McKesson、Schneider National","url":"https://stock-news.laohu8.com/highlight/detail?id=2453792825","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453792825?lang=zh_cn&edition=full","pubTime":"2024-07-22 23:31","pubTimestamp":1721662281,"startTime":"0","endTime":"0","summary":"    路透7月22日 - 华尔街证券分析师周一调整了对 Align Technology、McKesson 和 Schneider National 等几家美国上市公司的评级和目标价。* McKesson Corp   ：瑞银将目标价从630美元上调至670美元              * Schneider National   ：美国银行全球研究将其评级从 \"中性 \"下调至 \"跑输大市\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AN","ADC","LU2242652126.USD","BANR","ALX","ANAB","BANF","ACM","BRBR","AES","LU1880398554.USD","AAL","BGS","BHP","TXG","AXL","IE0034235188.USD","AUGX","LU","PINE","BK4141","AMZN","BCBP","AA","BCML","BE","ALV","LU1244550221.USD","AXP","AVBP","AXSM","BKU","BHLB","AGEN","ANF","AMRC","BAC","BMI","AMD","AEP","ARCB","LU0149725797.USD","PPG","ALGN","APA","BNTC","OZK","CMA","AGCO","LU0476273544.USD"],"gpt_icon":0},{"id":"2453928627","title":"Anaptysbio, Inc.盘中异动 早盘急速上涨5.12%报35.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2453928627","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453928627?lang=zh_cn&edition=full","pubTime":"2024-07-22 23:18","pubTimestamp":1721661488,"startTime":"0","endTime":"0","summary":"北京时间2024年07月22日23时18分，Anaptysbio, Inc.股票出现异动，股价急速上涨5.12%。截至发稿，该股报35.43美元/股，成交量7.5317万股，换手率0.28%，振幅4.33%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Apollomics Inc C/Wts 01/04/2028 、木薯科学涨幅较大，Hepion Pharmaceuticals, Inc.、Scisparc Ltd.、Mei Pharma, Inc.较为活跃，换手率分别为116.51%、101.71%、56.89%，振幅较大的相关个股有Anew Medical Inc C/Wts 21/06/2029 、木薯科学、Mei Pharma, Inc.，振幅分别为44.07%、33.41%、32.17%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722231808941f9344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240722231808941f9344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2452476036","title":"Anaptysbio, Inc.盘中异动 早盘股价大涨7.40%报37.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452476036","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452476036?lang=zh_cn&edition=full","pubTime":"2024-07-19 21:31","pubTimestamp":1721395886,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日21时31分，Anaptysbio, Inc.股票出现异动，股价急速上涨7.40%。截至发稿，该股报37.00美元/股，成交量3.1067万股，换手率0.11%，振幅0.83%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，60 Degrees Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，60 Degrees Pharmaceuticals, Inc.、Silo Pharma, Inc.、Altamira Therapeutics Ltd.较为活跃，换手率分别为557.74%、213.28%、105.78%，振幅较大的相关个股有60 Degrees Pharmaceuticals, Inc.、Altamira Therapeutics Ltd.、Solid Biosciences Inc.，振幅分别为16.26%、8.96%、7.05%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192131269f6bebd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407192131269f6bebd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2452946644","title":"Anaptysbio, Inc.盘中异动 股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452946644","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452946644?lang=zh_cn&edition=full","pubTime":"2024-07-17 02:13","pubTimestamp":1721153618,"startTime":"0","endTime":"0","summary":"北京时间2024年07月17日02时13分，Anaptysbio, Inc.股票出现异动，股价急速上涨5.29%。截至发稿，该股报34.44美元/股，成交量22.1172万股，换手率0.81%，振幅4.57%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Silo Pharma, Inc.、Nutriband Inc C/Wts 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Silo Pharma, Inc.、Scisparc Ltd.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3779.35%、1318.46%、417.69%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Nutriband Inc C/Wts 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为79.41%、70.56%、68.00%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717021338af929cdb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240717021338af929cdb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","RA"],"gpt_icon":0},{"id":"2451756176","title":"Anaptysbio, Inc.盘中异动 急速拉升5.32%报31.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451756176","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451756176?lang=zh_cn&edition=full","pubTime":"2024-07-16 01:25","pubTimestamp":1721064323,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日01时25分，Anaptysbio, Inc.股票出现异动，股价大幅上涨5.32%。截至发稿，该股报31.70美元/股，成交量8.083万股，换手率0.30%，振幅7.31%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Aeon Biopharma, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Scinai Immunotherapeutics Ltd、Qualigen Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为3329.69%、155.51%、131.08%，振幅较大的相关个股有Aeon Biopharma, Inc.、Scinai Immunotherapeutics Ltd、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为150.36%、91.37%、74.53%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716012523941f718c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716012523941f718c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"gpt_icon":0},{"id":"2450476845","title":"Anaptysbio, Inc.盘中异动 下午盘快速上涨5.12%报27.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450476845","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450476845?lang=zh_cn&edition=full","pubTime":"2024-07-11 01:27","pubTimestamp":1720632439,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日01时27分，Anaptysbio, Inc.股票出现波动，股价快速拉升5.12%。截至发稿，该股报27.10美元/股，成交量7.3148万股，换手率0.27%，振幅4.65%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为1.48%。其相关个股中，Kazia Therapeutics Limited、Virpax Pharmaceuticals, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Virpax Pharmaceuticals, Inc.、Soligenix, Inc.、Kazia Therapeutics Limited较为活跃，换手率分别为3997.75%、1491.66%、1226.65%，振幅较大的相关个股有Kazia Therapeutics Limited、Revolution Medicines Inc C/Wts 17/12/2026 、Virpax Pharmaceuticals, Inc.，振幅分别为421.88%、133.16%、119.83%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711012719af91a26a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711012719af91a26a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB","BK4007","VRPX","RA"],"gpt_icon":0},{"id":"2448483590","title":"Anaptysbio, Inc.盘中异动 快速上涨5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448483590","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448483590?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:31","pubTimestamp":1720013513,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时31分，Anaptysbio, Inc.股票出现异动，股价大幅拉升5.47%。截至发稿，该股报25.25美元/股，成交量8365股，换手率0.03%，振幅0.38%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，Cns Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Cns Pharmaceuticals, Inc.、Annovis Bio, Inc.、Seastar Medical Holding Corporation较为活跃，换手率分别为2143.69%、9.58%、3.57%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cns Pharmaceuticals, Inc.、Neurosense Therapeutics Ltd.，振幅分别为37.74%、19.05%、7.41%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703213153aef7c9b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703213153aef7c9b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2435888786","title":"美国研究综述-Altus Power、Jack in the Box、Home Depot","url":"https://stock-news.laohu8.com/highlight/detail?id=2435888786","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435888786?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:18","pubTimestamp":1715757518,"startTime":"0","endTime":"0","summary":"    路透5月15日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Altus Power、Jack in the Box 和 Home Depot。* Jack in the Box Inc   ：Wedbush将目标价从78美元下调至68美元 * Home Depot Inc   ：TD Cowen将目标价从440美元下调至420美元 以下是路透周三报导的美国公司研究行动摘要。* Altus Power Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4534","LQDA","ANAB","RLYB","PACS","JACK","BK4023","OXY","BK4504","LU1989772923.USD","IE00BZ1G4Q59.USD","IE0031619046.USD","AMPS","ANNX","IE00BWXC8680.SGD","PGNY","BK4083","HLVX","LU0823411888.USD","BK4088","BK4150","IE00B66KJ199.SGD","LU0820562030.AUD","SG9999001440.SGD","BK4588","BK4581","BK4539","LU0868494617.USD","VECO","BK4133","SDHC","BK4533","PHUN","CRIS","HROW","LU1989772840.SGD","HQI","BK4154","BK4585","LU1496350502.SGD","IGT","BK4130","BOLT","BK4185","LU1093756168.USD","AVIR","NUVL","IE00BSNM7G36.USD","HD"],"gpt_icon":0},{"id":"2435820688","title":"美国研究综述-Altus Power、Jack in the Box、Home Depot","url":"https://stock-news.laohu8.com/highlight/detail?id=2435820688","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435820688?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:18","pubTimestamp":1715757518,"startTime":"0","endTime":"0","summary":"    路透5月15日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Altus Power、Jack in the Box 和 Home Depot。* Jack in the Box Inc   ：Wedbush将目标价从78美元下调至68美元 * Home Depot Inc   ：TD Cowen将目标价从440美元下调至420美元 以下是路透周三报道的美国公司研究行动摘要。* Altus Power Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE00BWXC8680.SGD","BK4533","BK4088","LU1989772840.SGD","CRIS","JACK","LU0820562030.AUD","LQDA","LU1496350502.SGD","LU1989772923.USD","BK4133","HQI","IGT","BK4154","BK4150","IE00BZ1G4Q59.USD","LU0868494617.USD","BK4185","BK4581","PACS","BK4023","HLVX","IE00BSNM7G36.USD","BK4504","BOLT","BK4130","RLYB","LU0823411888.USD","PHUN","BK4139","BK4585","SDHC","IE0031619046.USD","LU1093756168.USD","AMPS","PGNY","NUVL","BK4083","ANAB","AVIR","IE00B66KJ199.SGD","HROW","SG9999001440.SGD","VECO","BK4588","OXY","ANNX","HD","BK4539"],"gpt_icon":0},{"id":"2433232208","title":"AnaptysBio Inc   预计每股亏损1.57美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433232208","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2433232208?lang=zh_cn&edition=full","pubTime":"2024-05-07 20:06","pubTimestamp":1715083582,"startTime":"0","endTime":"0","summary":"   * AnaptysBio Inc    预计在5月9日公布的截至2024年3月31日的业绩报告中将显示季度收入增长(预计)    * 根据LSEG的数据，10位分析师的平均预期显示，这家总部位于加利福尼亚州圣地亚哥的公司的营收预计将从一年前的137万美元增长188.7%，达到396.7万美元。* LSEG分析师对AnaptysBio公司的平均预期是每股亏损1.57美元。* 华尔街对 AnaptysBio Inc 的 12 个月目标价中位数为 47.00 美元，高于其最新收盘价 25.77 美元。5月7日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANAB"],"gpt_icon":0},{"id":"2432525506","title":"Anaptysbio, Inc.盘中异动 股价大涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432525506","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432525506?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:36","pubTimestamp":1714574161,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日22时36分，Anaptysbio, Inc.股票出现波动，股价快速拉升5.38%。截至发稿，该股报25.65美元/股，成交量13.0073万股，换手率0.48%，振幅4.72%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Cytomx Therapeutics, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Brainstorm Cell Therapeutics Inc.涨幅较大，Palisade Bio, Inc.、Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为1208.30%、141.07%、34.88%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024、Palisade Bio, Inc.，振幅分别为188.34%、66.20%、32.84%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012236017925a245&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012236017925a245&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","ANAB","BK4139"],"gpt_icon":0},{"id":"2431322916","title":"Anaptysbio, Inc.盘中异动 早盘股价大涨5.16%报22.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431322916","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431322916?lang=zh_cn&edition=full","pubTime":"2024-04-30 22:13","pubTimestamp":1714486437,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日22时13分，Anaptysbio, Inc.股票出现波动，股价大幅拉升5.16%。截至发稿，该股报22.40美元/股，成交量10.242万股，换手率0.37%，振幅6.21%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.65%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Cyclacel Pharmaceuticals, Inc.、Biorestorative Therapies, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为854.15%、206.19%、13.00%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Dare Bioscience, Inc.、Eliem Therapeutics, Inc，振幅分别为46.79%、37.46%、32.47%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302213577a57c2ab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404302213577a57c2ab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","RA","BK4139"],"gpt_icon":0},{"id":"2431864981","title":"Anaptysbio, Inc.盘中异动 急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431864981","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2431864981?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:09","pubTimestamp":1714399778,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时09分，Anaptysbio, Inc.股票出现异动，股价急速上涨5.00%。截至发稿，该股报22.05美元/股，成交量4.2259万股，换手率0.15%，振幅4.14%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.98%。其相关个股中，Soleno Therapeutics, Inc.、Immunitybio, Inc.、Ginkgo Bioworks Holdings, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Biodexa Pharmaceuticals Plc、Avenue Therapeutics, Inc.较为活跃，换手率分别为860.11%、33.41%、16.93%，振幅较大的相关个股有Cassava Sciences Inc C/Wts 15/11/2024、Zyversa Therapeutics, Inc.、Immunitybio, Inc.，振幅分别为33.33%、31.06%、29.01%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042922093887e84c1e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042922093887e84c1e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RA","BK4139","ANAB"],"gpt_icon":0},{"id":"2430788849","title":"Anaptysbio, Inc.盘中异动 急速上涨5.09%报19.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430788849","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2430788849?lang=zh_cn&edition=full","pubTime":"2024-04-27 00:24","pubTimestamp":1714148662,"startTime":"0","endTime":"0","summary":"北京时间2024年04月27日00时24分，Anaptysbio, Inc.股票出现异动，股价大幅拉升5.09%。截至发稿，该股报19.83美元/股，成交量11.7075万股，换手率0.43%，振幅5.91%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Biodexa Pharmaceuticals Plc、Zura Bio Limited C/Wts 、Cassava Sciences Inc C/Wts 15/11/2024涨幅较大，Biodexa Pharmaceuticals Plc、Kintara Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1361.24%、119.27%、46.86%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Psyence Biomedical Ltd C/Wts 25/01/2029、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为82.78%、81.90%、66.85%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240427002422861e9974&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240427002422861e9974&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANAB","BK4139","RA"],"gpt_icon":0},{"id":"2428712805","title":"美国研究综述-先进微设备公司、克罗格公司、泰森食品公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2428712805","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2428712805?lang=zh_cn&edition=full","pubTime":"2024-04-17 02:04","pubTimestamp":1713290698,"startTime":"0","endTime":"0","summary":"    路透社4月16日 - 华尔街证券分析师周二调整了对多家美国上市公司的评级和目标价，其中包括先进微设备公司、克罗格公司和泰森食品公司。* Kroger Co   ：富国银行将其评级从等权重上调至增持 * Tyson Foods Inc   ：巴克莱将其评级从 \"减持 \"上调至 \"增持\"。* 10X Genomics Inc   ：古根海姆将其目标价从 60 美元下调至 50 美元 * Advanced Micro Devices   ：Evercore ISI给予其 \"跑赢大盘 \"评级，目标价200美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APH","CHCT","IE00B19Z9Z06.USD","SCHW","ALAB","KR","AFRM","AVGO","CBUS","KOF","AESI","BK4529","ALGM","BK4551","CL","CAVA","AMD","BERY","CLX","CAT","EAT","LU0719512351.SGD","BA","BOOT","CNO","BK4093","ANAB","AMGN","LU0052756011.USD","SAM","CINF","ADI","GOOGL","TXG","IE00BWXC8680.SGD","CMG","AVTX","AL","AIG","CHTR","AMZN","LU0276348264.USD","LU0672654240.SGD","CF","TSN","AGCO","IE00B19Z3581.USD","AMAT","BRO","ALPN"],"gpt_icon":0},{"id":"2427865318","title":"Anaptysbio, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427865318","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2427865318?lang=zh_cn&edition=full","pubTime":"2024-04-16 00:46","pubTimestamp":1713199578,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日00时46分，Anaptysbio, Inc.股票出现异动，股价急速下跌5.17%。截至发稿，该股报21.54美元/股，成交量8.7417万股，换手率0.33%，振幅6.61%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、安皮奥制药、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大，Longeveron Inc.、Soligenix, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1464.50%、1200.31%、830.09%，振幅较大的相关个股有安皮奥制药、Soligenix, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为273.33%、114.53%、80.04%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041600461887e8081a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041600461887e8081a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2426925075","title":"Anaptysbio, Inc.股价上涨10.51% 市值涨6891.35万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426925075","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426925075?lang=zh_cn&edition=full","pubTime":"2024-04-11 21:31","pubTimestamp":1712842277,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日21时31分，Anaptysbio, Inc.股票出现异动，股价大幅拉升10.51%。截至发稿，该股报24.50美元/股，成交量1.6026万股，换手率0.06%，振幅5.05%。Anaptysbio, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Rallybio Corporation、Eliem Therapeutics, Inc、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Scisparc Ltd.、Aptevo Therapeutics Inc.、Rallybio Corporation较为活跃，换手率分别为325.80%、236.82%、75.37%，振幅较大的相关个股有Rallybio Corporation、Enliven Therapeutics, Inc.、Cassava Sciences Inc C/Wts 15/11/2024，振幅分别为13.50%、11.86%、11.71%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112131178b108e99&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404112131178b108e99&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","ANAB","RLYB"],"gpt_icon":0},{"id":"2426140911","title":"Anaptysbio, Inc.盘中异动 大幅拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426140911","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2426140911?lang=zh_cn&edition=full","pubTime":"2024-04-10 03:33","pubTimestamp":1712691232,"startTime":"0","endTime":"0","summary":"北京时间2024年04月10日03时33分，Anaptysbio, Inc.股票出现波动，股价大幅拉升5.08%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。其相关个股中，Biocardia Inc C/Wts 06/08/2024、Acrivon Therapeutics, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Mymd Pharmaceuticals, Inc.、Acrivon Therapeutics, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为490.57%、164.71%、151.54%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Nutriband Inc C/Wts 、Vbi Vaccines, Inc.，振幅分别为118.42%、87.27%、71.66%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。其在研产品为ANB020、ANB019和Checkpoint受体激动剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404100333537a51aadf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404100333537a51aadf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2424316086","title":"Anaptysbio, Inc.盘中异动 早盘股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424316086","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2424316086?lang=zh_cn&edition=full","pubTime":"2024-04-04 23:11","pubTimestamp":1712243481,"startTime":"0","endTime":"0","summary":"北京时间2024年04月04日23时11分，Anaptysbio, Inc.股票出现异动，股价大幅上涨5.02%。截至发稿，该股报21.76美元/股，成交量6.3537万股，换手率0.24%，振幅5.26%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Tc Biopharm  Plc涨幅较大，Tc Biopharm  Plc、Effector Therapeutics, Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为3138.73%、162.18%、94.36%，振幅较大的相关个股有Tc Biopharm  Plc、Tc Biopharm  Plc C/Wts 10/02/2028 、Tevogen Bio Holdings Inc.，振幅分别为90.00%、71.00%、56.49%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040423112287e7e0c0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040423112287e7e0c0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB"],"gpt_icon":0},{"id":"2421846790","title":"Anaptysbio, Inc.盘中异动 临近午盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421846790","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2421846790?lang=zh_cn&edition=full","pubTime":"2024-03-22 23:58","pubTimestamp":1711123086,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日23时58分，Anaptysbio, Inc.股票出现异动，股价急速跳水5.09%。截至发稿，该股报23.21美元/股，成交量16.8722万股，换手率0.63%，振幅4.83%。Anaptysbio, Inc.股票所在的生物技术行业中，整体跌幅为0.06%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Virios Therapeutics, Inc.、Effector Therapeutics Inc C/Wts 31/12/2025 涨幅较大，Outlook Therapeutics, Inc.、180 Life Sciences Corp.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为83.16%、39.31%、27.26%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Matinas Biopharma Holdings, Inc.、Outlook Therapeutics, Inc.，振幅分别为60.74%、59.24%、44.03%。Anaptysbio, Inc.公司简介：AnaptysBio Inc 是一家临床阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222358067a4e8d44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403222358067a4e8d44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ANAB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anaptysbio.com","stockEarnings":[{"period":"1week","weight":0.0917},{"period":"1month","weight":0.4879},{"period":"3month","weight":0.8618},{"period":"6month","weight":0.508},{"period":"1year","weight":0.9708},{"period":"ytd","weight":0.6671}],"compareEarnings":[{"period":"1week","weight":-0.0123},{"period":"1month","weight":0.0186},{"period":"3month","weight":0.0969},{"period":"6month","weight":0.1427},{"period":"1year","weight":0.2266},{"period":"ytd","weight":0.1669}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AnaptysBio, Inc.在特拉华成立于2005年11月。该公司是一家为了满足治疗消除炎症和免疫肿瘤的需求，而开发先入级抗体产品。他们开发使用自己的专利-抗体筛选技术平台，其平台目的是复制在体外的候选产品，以抗体产生的自然过程。他们的收入来源是合作研究和开发安排。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.00144},{"month":2,"riseRate":0.875,"avgChangeRate":0.0982},{"month":3,"riseRate":0.25,"avgChangeRate":-0.083331},{"month":4,"riseRate":0.375,"avgChangeRate":0.003799},{"month":5,"riseRate":0.375,"avgChangeRate":-0.031718},{"month":6,"riseRate":0.625,"avgChangeRate":0.007623},{"month":7,"riseRate":0.5,"avgChangeRate":0.023358},{"month":8,"riseRate":0.571429,"avgChangeRate":0.032135},{"month":9,"riseRate":0.571429,"avgChangeRate":0.022456},{"month":10,"riseRate":0.714286,"avgChangeRate":0.280813},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.09828},{"month":12,"riseRate":0.714286,"avgChangeRate":0.114651}],"exchange":"NASDAQ","name":"Anaptysbio Inc","nameEN":"Anaptysbio Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Anaptysbio Inc(ANAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Anaptysbio Inc,ANAB,Anaptysbio Inc股票,Anaptysbio Inc股票老虎,Anaptysbio Inc股票老虎国际,Anaptysbio Inc行情,Anaptysbio Inc股票行情,Anaptysbio Inc股价,Anaptysbio Inc股市,Anaptysbio Inc股票价格,Anaptysbio Inc股票交易,Anaptysbio Inc股票购买,Anaptysbio Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Anaptysbio Inc(ANAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Anaptysbio Inc(ANAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况